2022
DOI: 10.1002/ppul.25921
|View full text |Cite
|
Sign up to set email alerts
|

Repeatability of lung clearance index in infants with cystic fibrosis and recurrent wheeze

Abstract: Objectives: To describe the short-and medium-term repeatability of lung clearance index at 2.5% (LCI 2.5 ) in infants and calculate the number of patients needed to enroll in a study (N) using LCI 2.5 as a primary outcome.Methods: An 8-month follow-up observational study was employed for assessing short-term [coefficient of repeatability (CR) and intraclass correlation (ICC)] and medium-term repeatability (Bland-Altman method) of LCI 2.5 in infants with cystic fibrosis (CF) or recurrent wheeze (RW) measured by… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 30 publications
0
1
0
Order By: Relevance
“…To be able to utilize N 2 ‐MBW as a tool to monitor lung disease, data on the variability of this measurement are needed. Koucky et al 9 performed serial N 2 ‐MBW in a cohort of infants with CF and recurrent wheezing and established short‐term and medium‐term variability of in LCI. These data will be helpful in planning future studies.…”
Section: Introductionmentioning
confidence: 99%
“…To be able to utilize N 2 ‐MBW as a tool to monitor lung disease, data on the variability of this measurement are needed. Koucky et al 9 performed serial N 2 ‐MBW in a cohort of infants with CF and recurrent wheezing and established short‐term and medium‐term variability of in LCI. These data will be helpful in planning future studies.…”
Section: Introductionmentioning
confidence: 99%